البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
MAVACOXIB
ZOETIS ISRAEL HOLDING B.V., ISRAEL
CHEWABLE TABLETS
MAVACOXIB 95 MG
PER OS
Required
PFIZER ITALIA S.R.L., ITALY
For the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated
2018-06-30
1 Trocoxil LPD 14.10.2021 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Trocoxil 20 mg Chewable Tablets Veterinary Trocoxil 30 mg Chewable Tablets Veterinary Trocoxil 75 mg Chewable Tablets Veterinary Trocoxil 95 mg Chewable Tablets Veterinary 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains: ACTIVE SUBSTANCE: Mavacoxib 20 mg Mavacoxib 30 mg Mavacoxib 75 mg Mavacoxib 95 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablets Triangular tablet with mottled brown appearance embossed with the tablet strength on one side. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs aged 12 months or more. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated. 4.3 CONTRAINDICATIONS Do not use in dogs less than 12 months of age and/or less than 7 kg body weight Do not use in dogs suffering from gastro-intestinal disorders including ulceration and bleeding. Do not use where there is evidence of a haemorrhagic disorder. Do not use in cases of impaired renal or hepatic function Do not use in cases of cardiac insufficiency Do not use in pregnant, breeding or lactating dogs. Do not use in case of hypersensitivity to the active substance or to any of the excipients Do not use in cases of known hypersensitivity to sulphonamides. Do not use concomitantly with glucocorticoids or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), see section 4.8. Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. 2 Trocoxil LPD 14.10.2021 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Do not administer other NSAIDs or glucocorticoids concurrently or within 1 month of the last administration of Trocoxil. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Mavacoxib exhibits an extended plasma half life (up to > 80 days, see section 5.2) due to its l اقرأ الوثيقة كاملة